JNK-IN-8

JNK pathway inhibitor; Inhibits JNK1, JNK2, and JNK3

产品优势

未找到
Inhibit c-Jun N-terminal kinase (JNK) signaling with JNK-IN-8, an irreversible inhibitor of JNK1 (IC50 = 4.67 nM), JNK2 (IC50 = 18.7 nM), and JNK3 (IC50 = 0.98 nM). JNK-IN-8 inhibits JNK signaling by inhibiting the phosphorylation of the JNK substrate, c-Jun (Zhang et al. Chem Biol, 2012). JNKs are involved in regulating cell proliferation, differentiation, survival, and inflammation. Dysregulated JNK signaling has been associated with cancer as well as inflammatory and neurodegenerative diseases (Hammouda et al. Cells, 2020).

JNK-IN-8 has been used for:

CANCER RESEARCH
· Suppress colony formation and cell viability in human triple-negative breast cancer (TNBC) organoids and slow tumor growth in a mouse xenograft model (Soleimani et al. Mol Cancer Ther, 2022).
· Promote apoptosis and reduce clonogenic survival in human colorectal cancer organoids (Sun et al. Oncogene, 2021).
· Reduce tumor growth and regulatory T cell infiltration and increase infiltration of CD8+ T cells in a TNBC mouse model (Semba et al. J Natl Cancer Inst, 2022).
· Reduce cell viability of human and mouse B-lymphoblastic leukemia cells and slow leukemia progression in a mouse model (Xiao et al. J Hematol Oncol, 2020).
未找到

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Product Name
JNK-IN-8
Catalog #
100-1654
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
JNK-IN-8
Catalog #
100-1654
Lot #
All
Language
English
未找到
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。